Patient Preference for Once-Weekly Dosing in Type 2 Diabetes Mellitus in Japan
**Background:** Among several factors that impair adherence to available therapies in type 2 diabetes mellitus (T2DM) is the complexity of the dosing regimen. Moreover, the value of a once-weekly (QW) administration of oral medications for T2DM compared to once, twice, or thrice daily (QD, BID, TID)...
Saved in:
Main Authors: | Rohini Sen, Alan L. Shields, Koichiro Atsuda |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2016-03-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9826 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes
by: Noelle N. Gronroos, et al.
Published: (2024-11-01) -
Efficacy and safety of once-weekly semaglutide monotherapy in a young subject with Prader-Willi syndrome, obesity, and type 2 diabetes: a case report
by: Elisa Dinoi, et al.
Published: (2025-02-01) -
Liver Damage in Type 1 Diabetes Mellitus
by: A. O. Bueverov, et al.
Published: (2021-06-01) -
Impact of COVID-19 on metabolic parameters in patients with type 2 diabetes mellitus
by: Motahare Shabestari, et al.
Published: (2025-02-01) -
Rett syndrome complicated by diabetes mellitus type 1
by: Yasutaka Kuniyoshi, et al.
Published: (2025-02-01)